NYSE: MDT
Medtronic plc Stock

MDT Price
$107.93
Fair Value Price
N/A
Market Cap
$144.77B
52 Week Low
$72.92
52 Week High
$121.30
P/E
32.81x
P/B
2.88x
P/S
4.64x
PEG
1.33x
Dividend Yield
2.04%
Revenue
$27.93B
Earnings
$4.41B
Gross Profit Margin
65.8%
Operating Margin
15.43%
Net Profit Margin
15.8%
Debt to Equity
0.86
Operating Cash Flow
$6B
Beta
0.89
Next Earnings
Nov 24, 2020
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
49
Industry average

Reasons for this score

MDT ($107.93) is trading below its intrinsic value of $309.43, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
MDT is good value based on its earnings relative to its share price (32.81x), compared to the US market average 42.6x)
Valuation
MDT is good value based on its earnings relative to its share price (32.81x), compared to the US Medical Devices industry average (83.05x)
Valuation

1 of 13

MDT News

Valuation

MDT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
32.81x
Industry
83.05x
Market
42.6x
MDT is good value based on its earnings relative to its share price (32.81x), compared to the US market average 42.6x)
Valuation
MDT is good value based on its earnings relative to its share price (32.81x), compared to the US Medical Devices industry average (83.05x)
Valuation

MDT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.88x
Industry
10.32x
Market
62.61x
MDT is good value based on its book value relative to its share price (2.88x), compared to the US market average (62.61x)
Valuation
MDT is good value based on its book value relative to its share price (2.88x), compared to the US Medical Devices industry average (10.32x)
Valuation

MDT price to earnings growth (PEG)

For valuing profitable companies with growth potential
MDT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.33x)
Valuation

MDT's financial health

Profit margin

Revenue
$6.0B
Net Income
$646.0M
Profit Margin
10.8%
MDT's Earnings (EBIT) of $4.31B can safely cover interest payments on company debt ($28.69B)
Financials
MDT's profit margin has increased (+1.4%) in the last year from (14.4%) to (15.8%)
Financials

Assets to liabilities

Assets
$90.7B
Liabilities
$39.8B
Debt to equity
0.49
MDT's short-term assets ($24.51B) exceed its short-term liabilities ($13.09B)
Financials
MDT's long-term liabilities ($30.38B) exceed its short-term assets ($24.51B)
Financials
MDT's debt relative to shareholder equity (0.86) has decreased or remained constant compared to 5 years ago (0.98)
Financials
MDT's debt to equity ratio (0.86) is considered high
Financials

Cash flow

Operating
$1.5B
Investing
$365.0M
Financing
-$1.3B
MDT's operating cash flow ($6.00B) is sufficient to service the company's debt ($28.69B)
Financials

Medtronic Stock FAQ

(NYSE: MDT) Medtronic trades on the NYSE under the ticker symbol MDT. Medtronic stock quotes can also be displayed as NYSE: MDT.
(NYSE: MDT) Medtronic stock price per share is $107.93 today (as of Oct 26, 2020).
(NYSE: MDT) Medtronic's 52-week high was $121.30, and its 52-week low was $72.92. It is currently -11.02% from its 52-week high and 48.01% from its 52-week low.
(NYSE: MDT) Medtronic's market cap is $144.77B, as of Oct 27, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medtronic's market cap is calculated by multiplying MDT's current stock price of $107.93 by MDT's total outstanding shares of 1341298882.
(NYSE: MDT) Medtronic currently has 1341298882 outstanding shares. With Medtronic stock trading at $107.93 per share, the total value of Medtronic stock (market capitalization) is $144.77B.

Medtronic stock was originally listed at a price of $26.25 in Dec 31, 1997. If you had invested in Medtronic stock at $26.25, your return over the last 22 years would have been 311.16%, for an annualized return of 6.64%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics